Agoracom: Small Cap Investment - Resverlogix Corp.

GeorgeParros

posted on Jul 28, 2020 05:23PM

"Type 2 Diabetics with CVD • Phase 3 trial BETonMACE2 is planned with 5,000 - 6,000 patients with T2DM, recent ACS and low HDL levels"

Is the medical trial design parameters for BOM2 any different than BOM (1) except for the much larger patient trial?

Koo

1 Recommendations

cityslicker99

Jul 28, 2020 07:30PM

tada

Jul 28, 2020 07:56PM

Jul 31, 2020 09:44AM

Jul 31, 2020 01:31PM

Jul 31, 2020 01:49PM

Jul 31, 2020 06:14PM

Jul 31, 2020 06:16PM

Jul 31, 2020 06:33PM

tada

Aug 01, 2020 04:22AM

Aug 01, 2020 08:32AM

narmac

Aug 01, 2020 11:52AM

Aug 01, 2020 03:10PM

Aug 01, 2020 03:14PM

10-41

Aug 01, 2020 09:09PM

cityslicker99

Aug 02, 2020 03:42PM

Re: New RVX Tweet - This is twisting my poor brain....Anyone?

narmac

Aug 02, 2020 09:39PM

Re: New RVX Tweet - This is twisting my poor brain....Anyone?

Aug 03, 2020 07:21PM

Aug 03, 2020 07:21PM

Re: New RVX Tweet - This is twisting my poor brain....Anyone?

Aug 04, 2020 12:15AM

Re: New RVX Tweet - This is twisting my poor brain....Anyone?

Aug 04, 2020 12:22AM

Aug 04, 2020 04:05AM

Aug 04, 2020 04:16AM

narmac

Aug 04, 2020 07:30AM

BearDownAZ

Aug 04, 2020 10:35AM